Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Soliman

Showing results (21-30 of 899) with videos related to

Pageof 90
Sort By:
Journal of Receptor and Signal Transduction Research|October 9, 2015
A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entryEmiliene Berinyuy, Mahmoud E S Soliman
Die Pharmazie|September 1, 1983
Novel indolene-spiro-hydroxytetronimides as potential antineoplastic and antiviral agentsF S Soliman, H M Salama
The European Respiratory Journal|March 1, 1997
The impact of inspiratory effort on inspiratory flow through Turbuhaler in asthmatic patientsG Persson, B Olsson, S Soliman
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 17, 2015
Short- and Long-Term Outcomes of Student Field Research Experiences in Special PopulationsAmr S Soliman, Robert M Chamberlain
Die Pharmazie|July 1, 1976
alpha-(4-chloro-3-nitrophenyl)-beta-aminoethanols: potential beta-adrenergic blocking agentsR M Shafik, F S Soliman
Interdisciplinary Sciences, Computational Life Sciences|May 12, 2016
Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modellingEmiliene Berinyuy, Mahmoud E S Soliman
Current Pharmaceutical Biotechnology|October 28, 2020
The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 TreatmentClement Agoni, Mahmoud E S Soliman
Molecular Biosystems|February 8, 2017
Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virusMarissa Balmith, Mahmoud E S Soliman
Journal of Biomolecular Structure & Dynamics|March 30, 2017
Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discoveryPritika Ramharack, Mahmoud E S Soliman
Cell Biochemistry and Biophysics|February 2, 2017
VP40 of the Ebola Virus as a Target for EboV Therapy: Comprehensive Conformational and Inhibitor Binding Landscape from Accelerated Molecular DynamicsMarissa Balmith, Mahmoud E S Soliman
Pageof 90

Showing results (21-30 of 899) with videos related to

Sort By:
Pageof 90
Journal of Receptor and Signal Transduction Research|October 9, 2015
A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entryEmiliene Berinyuy, Mahmoud E S Soliman
Die Pharmazie|September 1, 1983
Novel indolene-spiro-hydroxytetronimides as potential antineoplastic and antiviral agentsF S Soliman, H M Salama
The European Respiratory Journal|March 1, 1997
The impact of inspiratory effort on inspiratory flow through Turbuhaler in asthmatic patientsG Persson, B Olsson, S Soliman
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 17, 2015
Short- and Long-Term Outcomes of Student Field Research Experiences in Special PopulationsAmr S Soliman, Robert M Chamberlain
Die Pharmazie|July 1, 1976
alpha-(4-chloro-3-nitrophenyl)-beta-aminoethanols: potential beta-adrenergic blocking agentsR M Shafik, F S Soliman
Interdisciplinary Sciences, Computational Life Sciences|May 12, 2016
Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modellingEmiliene Berinyuy, Mahmoud E S Soliman
Current Pharmaceutical Biotechnology|October 28, 2020
The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 TreatmentClement Agoni, Mahmoud E S Soliman
Molecular Biosystems|February 8, 2017
Non-active site mutations disturb the loop dynamics, dimerization, viral budding and egress of VP40 of the Ebola virusMarissa Balmith, Mahmoud E S Soliman
Journal of Biomolecular Structure & Dynamics|March 30, 2017
Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discoveryPritika Ramharack, Mahmoud E S Soliman
Cell Biochemistry and Biophysics|February 2, 2017
VP40 of the Ebola Virus as a Target for EboV Therapy: Comprehensive Conformational and Inhibitor Binding Landscape from Accelerated Molecular DynamicsMarissa Balmith, Mahmoud E S Soliman
Pageof 90